Clinical features, treatment strategies, and long-term outcomes of Blau syndrome: a 10-year experience from a Chinese cohort

Abstract Objectives Blau syndrome (BS) is a rare autoinflammatory disorder characterized by the clinical triad of uveitis, dermatitis, and arthritis. While the clinical spectrum is well-documented, data on the longitudinal efficacy and durability of tumor necrosis factor-α (TNF-α) inhibitors remain...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jingyuan Zhang, Min Shen
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-02-01
Schriftenreihe:	Advances in Rheumatology
Schlagworte:	Blau syndrome NOD2 protein Autoinflammatory diseases Tumor necrosis factor inhibitors Treatment outcome
Online-Zugang:	https://doi.org/10.1186/s42358-026-00528-0
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!